Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

The Anchoring-and-Adjustment Heuristic01:25

The Anchoring-and-Adjustment Heuristic

7.7K
In order to make good decisions, we use our knowledge and our reasoning. Often, this knowledge and reasoning is sound and solid. However, sometimes, we are swayed by biases or by others manipulating a situation. For example, let’s say you and three friends wanted to rent a house and had a combined target budget of $1,600. The realtor shows you only very run-down houses for $1,600 and then shows you a very nice house for $2,000. Might you ask each person to pay more in rent to get the...
7.7K
Decision Making: P-value Method01:09

Decision Making: P-value Method

6.8K
The process of hypothesis testing based on the P-value method includes calculating the P- value using the sample data and interpreting it.
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim  is also stated. These statements can act as null and alternative hypotheses:  a null hypothesis would be a neutral statement while the alternative hypothesis can...
6.8K
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

1.1K
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
1.1K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

240
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
240
Per-Unit Sequence Models01:26

Per-Unit Sequence Models

428
An ideal Y-Y transformer, grounded through neutral impedances, displays per-unit sequence networks akin to those of a single-phase ideal transformer when subjected to balanced positive- or negative-sequence currents. These currents do not produce neutral currents, and their associated voltage drops.
Zero-sequence currents, which are identical in magnitude and phase, generate a neutral current, resulting in voltage drops across the neutral impedance and the low-voltage winding. If the...
428
Weighted Mean00:57

Weighted Mean

6.2K
While taking the arithmetic, geometric, or harmonic mean of a sample data set, equal importance is assigned to all the data points. However, all the values may not always be equally important in some data sets. An intrinsic bias might make it more important to give more weightage to specific values over others.
For example, consider the number of goals scored in the matches of a tournament. While computing the average number of goals scored in the tournament, it may be more important to...
6.2K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Early Phase Dose-Finding Designs for CAR-T Cell Therapies.

Pharmaceutical statistics·2026
Same author

A randomized controlled Phase I de-escalation trial of molnupiravir and nirmatrelvir/ritonavir combination for mild-moderate SARS-CoV-2 infection.

The Journal of antimicrobial chemotherapy·2026
Same author

An evaluation of designs for Phase I/IIa dose-finding studies in Tuberculosis.

Statistical methods in medical research·2026
Same author

On the Interplay Between Prior Weight and Variance of the Robustification Component in Robust Mixture Prior Bayesian Dynamic Borrowing Approach.

Statistics in medicine·2026
Same author

Computationally Efficient Approach to Operational Prior Specification in Phase I Clinical Trials.

Statistics in medicine·2026
Same author

Modern Clinical Trials: Seamless Designs and Master Protocols.

Cancer medicine·2026
Same journal

A Bayesian functional concurrent zero-inflated Dirichlet-multinomial regression model with application to infant microbiome.

Biostatistics (Oxford, England)·2026
Same journal

Towards optimal environmental policies: policy learning under arbitrary bipartite network interference.

Biostatistics (Oxford, England)·2026
Same journal

Multilevel functional quantile principal component analysis.

Biostatistics (Oxford, England)·2026
Same journal

Adaptive transfer learning for time-to-event modeling with applications in disease risk assessment.

Biostatistics (Oxford, England)·2026
Same journal

High-dimensional test for one-sided hypotheses.

Biostatistics (Oxford, England)·2026
Same journal

NBSR: a Negative Binomial Softmax Regression model for microRNA-seq data analysis.

Biostatistics (Oxford, England)·2026
查看所有相关文章

相关实验视频

Updated: Jan 14, 2026

A Psychophysics Paradigm for the Collection and Analysis of Similarity Judgments
08:12

A Psychophysics Paradigm for the Collection and Analysis of Similarity Judgments

Published on: March 1, 2022

2.9K

贝叶斯模型对部分排序连续重新评估方法的平均值.

Luka Kovačević1, Weishi Chen1, Helen Barnett2

  • 1MRC Biostatistics Unit, East Forvie Building, Forvie Site, Robinson Way, Cambridge Biomedical Campus, Cambridge CB2 0SR, United Kingdom.

Biostatistics (Oxford, England)
|October 21, 2025
PubMed
概括
此摘要是机器生成的。

贝叶斯模型平均POCRM (BMA-POCRM) 通过解决剂量发现中的估计不一致性来增强药物组合试验. 这种新方法通过提供更准确的毒性估计,提高了患者的安全性和临床医生的信任.

关键词:
贝叶斯的推理 贝叶斯的推理适应性设计是适应性的设计.这是不连贯的不连贯性.最大的可容忍剂量.

更多相关视频

Measuring Attention and Visual Processing Speed by Model-based Analysis of Temporal-order Judgments
13:00

Measuring Attention and Visual Processing Speed by Model-based Analysis of Temporal-order Judgments

Published on: January 23, 2017

10.3K
Measuring Delay Discounting in Humans Using an Adjusting Amount Task
07:47

Measuring Delay Discounting in Humans Using an Adjusting Amount Task

Published on: January 9, 2016

16.0K

相关实验视频

Last Updated: Jan 14, 2026

A Psychophysics Paradigm for the Collection and Analysis of Similarity Judgments
08:12

A Psychophysics Paradigm for the Collection and Analysis of Similarity Judgments

Published on: March 1, 2022

2.9K
Measuring Attention and Visual Processing Speed by Model-based Analysis of Temporal-order Judgments
13:00

Measuring Attention and Visual Processing Speed by Model-based Analysis of Temporal-order Judgments

Published on: January 23, 2017

10.3K
Measuring Delay Discounting in Humans Using an Adjusting Amount Task
07:47

Measuring Delay Discounting in Humans Using an Adjusting Amount Task

Published on: January 9, 2016

16.0K

科学领域:

  • 临床药理学 临床药理学
  • 生物统计学 生物统计学
  • 药物开发 药物开发

背景情况:

  • 第一期临床试验对于推进新疗法至关重要.
  • 传统的剂量确定方法,如3+3和持续重新评估方法 (CRM),在组合药物试验中扎着不确定性.
  • 组合试验涉及多种药物的同时剂量升级,从而产生复杂的剂量-毒性关系.

研究的目的:

  • 解决用于组合药物试验的部分订单CRM (POCRM) 中的"估计不一致性"问题.
  • 为了引入和正式化贝叶斯模型,平均POCRM (BMA-POCRM) 作为一个解决方案.
  • 提供理论上的保证,并证明BMA-POCRM的有效性.

主要方法:

  • 该研究分析了POCRM对估计不一致性的脆弱性.
  • 贝叶斯模型平均化用于开发BMA-POCRM,同时考虑所有可能的剂量-毒性顺序.
  • 为POCRM和BMA-POCRM的估计连贯性获得理论保证.

主要成果:

  • 发现POCRM容易发生毒性估计的不合逻辑变化,从而危及患者的安全.
  • 通过对所有可能的订单进行平均计算,BMA-POCRM显著降低了估计不一致性的频率.
  • 模拟研究和一个特定的POCRM不一致案例表明BMA-POCRM的性能有所改善.

结论:

  • 在I期组合药物试验中,BMA-POCRM提供了一种更稳健,更安全的剂量确定方法.
  • 与标准POCRM相比,该方法提高了准确性和可靠性.
  • 在复杂的试验环境中,BMA-POCRM增加了临床医生的对剂量确定模型的信任.